The decrease in blood flow disrupts CV pruning. by Lin Wen (557398)

PGRN decreased Dectin-2 expression on the surface of macrophages and neutrophils. by Jiayu Liu (3951515)

Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Subjects:

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

FTY720 treatment decreased phosphorylation of AKT, ERK, and c-myc. by Laura L. Stafman (6577184)

“…(B) Immunoblotting for the activated form of ERK1/2 –phospho-ERK1/2 (Thr202/Tyr204, Thr185/Tyr187)–and total ERK1/2 revealed a decrease in phospho-ERK1/2 with no accompanying change in total ERK1/2, indicating a decrease in ERK signaling with FTY720 treatment. …”

Effect of MI to decrease depressive symptoms (fixed-effects model). by Kalayou Kidanu Berhe (9557751)

LCN2 treatment decreases the extent of hippocampal LTP in brain slices. by Jae-Hong Kim (124622)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Bach1 decreases Smad3 protein. by Katsushi Suzuki (9225735)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

The decrease in embryonic survival after stress coincides with a decrease in oocyte and embryo size. by Sarah Fausett (11812818)

Inhibition of p53 expression decreases TRAIL receptor-induced apoptosis. by Anna Willms (6556340)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

Knockdown of Ube2d proteins decreases ubiquitination of EGFR in HeLa cells. by Mariya S. Liyasova (3821908)

Decreased transcription of <i>prs</i> results in decreased growth. by Javiera Norambuena (137228)

Phosphorylation of PFK2 is decreased in cardiomyocytes cultured in the absence of insulin and with diabetes. by Craig A. Eyster (9262632)

“…Scale bar 10μm. (B) Quantitation of mean fluorescence intensity (MFI) for pPFK2 are presented as whisker plots that encompass data from at least 18 cells, as detailed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231806#pone.0231806.g001" target="_blank">Fig 1</a> (n = 3 biological replicates, and at least 6 cells per experiment). (*) IBMX or Isoproterenol treatment causes a significant increase (<i>p</i> < .001) compared to untreated WT cells; (†) Each WT (-ins) condition is significantly decreased (<i>p</i> < .001) compared to WT (+ins); (‡) all Akita conditions are significantly decreased (<i>p</i> < .001) compared to comparable WT conditions. …”

Inhibition of PKC or Rho protein kinase decreases Ad5 wild type replication <i>in vitro</i>. by Alice Liu (4814415)

MigC interacts with and decreases the activity of MurD. by Jeanette M. Critchlow (21553796)

Mitigation (decreasing) scenario. by Fabio Correddu (12501799)